AutoloGel

DEVICE5 trials

Sponsors

Cytomedix

Conditions

Diabetic Foot UlcerDiabetic Foot UlcersImpaired Wound HealingPressure UlcerVenous Leg Ulcer

Phase 4

A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers

WithdrawnNCT02248077

CytomedixImpaired Wound Healing

Start: 2014-10-31Updated: 2016-10-21

Unknown Phase

Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers

TerminatedNCT01816633

CytomedixDiabetic Foot Ulcers

Start: 2013-10-31End: 2015-01-31Updated: 2016-10-21

Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.

TerminatedNCT01816672

CytomedixDiabetic Foot Ulcer

Start: 2013-04-30End: 2015-07-31Updated: 2016-10-21

A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers

TerminatedNCT01817543

CytomedixVenous Leg Ulcer

Start: 2013-10-31End: 2015-01-31Updated: 2016-10-21

AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers

TerminatedNCT01819142

CytomedixPressure Ulcer

Start: 2013-04-30End: 2016-01-31Updated: 2016-10-21